How Big Will the SpaceX IPO Be?
Operated up to now as a private business, SpaceX will…
Buy
58
LH Quote, Financials, Valuation and Earnings
Last price:
$272.23
Seasonality move
:
6.5%
Day range:
$265.73 - $271.86
52-week range:
$209.38 - $293.72
Dividend yield:
1.07%
P/E ratio:
26.54x
P/S ratio:
1.65x
P/B ratio:
2.58x
Volume:
514.8K
Avg. volume:
748.9K
1-year change:
8.2%
Market cap:
$22.4B
Revenue:
$13B
EPS (TTM):
$10.18
Price Performance History
Performance vs. Valuation Benchmarks
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Competitors
| Company | Revenue Forecast | Earnings Forecast | Revenue Growth Forecast | Earnings Growth Forecast | Analyst Price Target Median |
|---|---|---|---|---|---|
|
LH
Labcorp Holdings, Inc.
|
$3.6B | $3.94 | 5.08% | 62.84% | $300.06 |
|
DCTH
Delcath Systems, Inc.
|
$20.4M | -$0.03 | 23.67% | 56.83% | $22.33 |
|
DGX
Quest Diagnostics, Inc.
|
$2.8B | $2.36 | 4.11% | 22.45% | $199.31 |
|
DHR
Danaher Corp.
|
$6.8B | $2.19 | 4.54% | 46.57% | $265.23 |
|
GH
Guardant Health, Inc.
|
$271.8M | -$0.47 | 35.29% | -43.18% | $125.24 |
|
WGS
GeneDx Holdings Corp.
|
$120.4M | $0.12 | 34.88% | -77.01% | $170.00 |
| Company | Price | Analyst Target | Market Cap | P/E Ratio | Dividend per Share | Dividend Yield | Price / LTM Sales |
|---|---|---|---|---|---|---|---|
|
LH
Labcorp Holdings, Inc.
|
$270.29 | $300.06 | $22.4B | 26.54x | $0.72 | 1.07% | 1.65x |
|
DCTH
Delcath Systems, Inc.
|
$9.98 | $22.33 | $352.4M | 1,147.13x | $0.00 | 0% | 4.76x |
|
DGX
Quest Diagnostics, Inc.
|
$185.00 | $199.31 | $20.6B | 21.71x | $0.80 | 1.73% | 1.93x |
|
DHR
Danaher Corp.
|
$223.42 | $265.23 | $157.9B | 44.26x | $0.32 | 0.57% | 6.51x |
|
GH
Guardant Health, Inc.
|
$114.90 | $125.24 | $14.9B | -- | $0.00 | 0% | 15.80x |
|
WGS
GeneDx Holdings Corp.
|
$99.01 | $170.00 | $2.9B | 1,641.96x | $0.00 | 0% | 7.06x |
| Company | Total Debt / Total Capital | Beta | Debt to Equity | Quick Ratio |
|---|---|---|---|---|
|
LH
Labcorp Holdings, Inc.
|
42.88% | 0.762 | 27.39% | 1.10x |
|
DCTH
Delcath Systems, Inc.
|
0.83% | 1.664 | 0.25% | 12.82x |
|
DGX
Quest Diagnostics, Inc.
|
46.79% | -0.045 | 30.05% | 0.90x |
|
DHR
Danaher Corp.
|
25.96% | 0.180 | 11.38% | 1.27x |
|
GH
Guardant Health, Inc.
|
136.47% | 0.817 | 16.98% | 2.94x |
|
WGS
GeneDx Holdings Corp.
|
28.13% | 1.929 | 3.68% | 2.47x |
| Company | Gross Profit | Operating Income | Return on Invested Capital | Return on Common Equity | EBIT Margin | Free Cash Flow |
|---|---|---|---|---|---|---|
|
LH
Labcorp Holdings, Inc.
|
$955.6M | $403.2M | 5.61% | 10.25% | 11.32% | $280.5M |
|
DCTH
Delcath Systems, Inc.
|
$17.9M | -$388K | 1.56% | 1.59% | -1.89% | $4.3M |
|
DGX
Quest Diagnostics, Inc.
|
$911M | $420M | 7.41% | 14.33% | 14.92% | $419M |
|
DHR
Danaher Corp.
|
$4B | $1.5B | 5.2% | 7.02% | 21.97% | $1.7B |
|
GH
Guardant Health, Inc.
|
$171.6M | -$99M | -36.05% | -8518.58% | -37.33% | -$45.8M |
|
WGS
GeneDx Holdings Corp.
|
$79.4M | -$3.1M | 0.56% | 0.82% | -2.68% | $9.6M |
Labcorp Holdings, Inc. vs. Competitors
-
Which has Higher Returns LH or DCTH?
Delcath Systems, Inc. has a net margin of 7.34% compared to Labcorp Holdings, Inc.'s net margin of 4.04%. Labcorp Holdings, Inc.'s return on equity of 10.25% beat Delcath Systems, Inc.'s return on equity of 1.59%.
Company Gross Margin Earnings Per Share Invested Capital LHLabcorp Holdings, Inc.26.82% $3.12 $15.2B DCTHDelcath Systems, Inc.87.24% $0.02 $115.8M -
What do Analysts Say About LH or DCTH?
Labcorp Holdings, Inc. has a consensus price target of $300.06, signalling upside risk potential of 11.01%. On the other hand Delcath Systems, Inc. has an analysts' consensus of $22.33 which suggests that it could grow by 123.78%. Given that Delcath Systems, Inc. has higher upside potential than Labcorp Holdings, Inc., analysts believe Delcath Systems, Inc. is more attractive than Labcorp Holdings, Inc..
Company Buy Ratings Hold Ratings Sell Ratings LHLabcorp Holdings, Inc.12 5 0 DCTHDelcath Systems, Inc.5 0 0 -
Is LH or DCTH More Risky?
Labcorp Holdings, Inc. has a beta of 1.029, which suggesting that the stock is 2.876% more volatile than S&P 500. In comparison Delcath Systems, Inc. has a beta of 0.373, suggesting its less volatile than the S&P 500 by 62.663%.
-
Which is a Better Dividend Stock LH or DCTH?
Labcorp Holdings, Inc. has a quarterly dividend of $0.72 per share corresponding to a yield of 1.07%. Delcath Systems, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Labcorp Holdings, Inc. pays 32.58% of its earnings as a dividend. Delcath Systems, Inc. pays out -- of its earnings as a dividend. Labcorp Holdings, Inc.'s payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.
-
Which has Better Financial Ratios LH or DCTH?
Labcorp Holdings, Inc. quarterly revenues are $3.6B, which are larger than Delcath Systems, Inc. quarterly revenues of $20.6M. Labcorp Holdings, Inc.'s net income of $261.5M is higher than Delcath Systems, Inc.'s net income of $830K. Notably, Labcorp Holdings, Inc.'s price-to-earnings ratio is 26.54x while Delcath Systems, Inc.'s PE ratio is 1,147.13x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Labcorp Holdings, Inc. is 1.65x versus 4.76x for Delcath Systems, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income LHLabcorp Holdings, Inc.1.65x 26.54x $3.6B $261.5M DCTHDelcath Systems, Inc.4.76x 1,147.13x $20.6M $830K
-
Which has Higher Returns LH or DGX?
Quest Diagnostics, Inc. has a net margin of 7.34% compared to Labcorp Holdings, Inc.'s net margin of 9.13%. Labcorp Holdings, Inc.'s return on equity of 10.25% beat Quest Diagnostics, Inc.'s return on equity of 14.33%.
Company Gross Margin Earnings Per Share Invested Capital LHLabcorp Holdings, Inc.26.82% $3.12 $15.2B DGXQuest Diagnostics, Inc.32.35% $2.15 $13.8B -
What do Analysts Say About LH or DGX?
Labcorp Holdings, Inc. has a consensus price target of $300.06, signalling upside risk potential of 11.01%. On the other hand Quest Diagnostics, Inc. has an analysts' consensus of $199.31 which suggests that it could grow by 7.74%. Given that Labcorp Holdings, Inc. has higher upside potential than Quest Diagnostics, Inc., analysts believe Labcorp Holdings, Inc. is more attractive than Quest Diagnostics, Inc..
Company Buy Ratings Hold Ratings Sell Ratings LHLabcorp Holdings, Inc.12 5 0 DGXQuest Diagnostics, Inc.7 8 0 -
Is LH or DGX More Risky?
Labcorp Holdings, Inc. has a beta of 1.029, which suggesting that the stock is 2.876% more volatile than S&P 500. In comparison Quest Diagnostics, Inc. has a beta of 0.662, suggesting its less volatile than the S&P 500 by 33.785%.
-
Which is a Better Dividend Stock LH or DGX?
Labcorp Holdings, Inc. has a quarterly dividend of $0.72 per share corresponding to a yield of 1.07%. Quest Diagnostics, Inc. offers a yield of 1.73% to investors and pays a quarterly dividend of $0.80 per share. Labcorp Holdings, Inc. pays 32.58% of its earnings as a dividend. Quest Diagnostics, Inc. pays out 39.15% of its earnings as a dividend. Both of these payout ratios are sufficient to cover dividend payouts with earnings for the foreseeable future.
-
Which has Better Financial Ratios LH or DGX?
Labcorp Holdings, Inc. quarterly revenues are $3.6B, which are larger than Quest Diagnostics, Inc. quarterly revenues of $2.8B. Labcorp Holdings, Inc.'s net income of $261.5M is higher than Quest Diagnostics, Inc.'s net income of $257M. Notably, Labcorp Holdings, Inc.'s price-to-earnings ratio is 26.54x while Quest Diagnostics, Inc.'s PE ratio is 21.71x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Labcorp Holdings, Inc. is 1.65x versus 1.93x for Quest Diagnostics, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income LHLabcorp Holdings, Inc.1.65x 26.54x $3.6B $261.5M DGXQuest Diagnostics, Inc.1.93x 21.71x $2.8B $257M
-
Which has Higher Returns LH or DHR?
Danaher Corp. has a net margin of 7.34% compared to Labcorp Holdings, Inc.'s net margin of 17.3%. Labcorp Holdings, Inc.'s return on equity of 10.25% beat Danaher Corp.'s return on equity of 7.02%.
Company Gross Margin Earnings Per Share Invested Capital LHLabcorp Holdings, Inc.26.82% $3.12 $15.2B DHRDanaher Corp.58% $1.68 $71B -
What do Analysts Say About LH or DHR?
Labcorp Holdings, Inc. has a consensus price target of $300.06, signalling upside risk potential of 11.01%. On the other hand Danaher Corp. has an analysts' consensus of $265.23 which suggests that it could grow by 18.71%. Given that Danaher Corp. has higher upside potential than Labcorp Holdings, Inc., analysts believe Danaher Corp. is more attractive than Labcorp Holdings, Inc..
Company Buy Ratings Hold Ratings Sell Ratings LHLabcorp Holdings, Inc.12 5 0 DHRDanaher Corp.18 3 0 -
Is LH or DHR More Risky?
Labcorp Holdings, Inc. has a beta of 1.029, which suggesting that the stock is 2.876% more volatile than S&P 500. In comparison Danaher Corp. has a beta of 0.916, suggesting its less volatile than the S&P 500 by 8.434%.
-
Which is a Better Dividend Stock LH or DHR?
Labcorp Holdings, Inc. has a quarterly dividend of $0.72 per share corresponding to a yield of 1.07%. Danaher Corp. offers a yield of 0.57% to investors and pays a quarterly dividend of $0.32 per share. Labcorp Holdings, Inc. pays 32.58% of its earnings as a dividend. Danaher Corp. pays out 25.35% of its earnings as a dividend. Both of these payout ratios are sufficient to cover dividend payouts with earnings for the foreseeable future.
-
Which has Better Financial Ratios LH or DHR?
Labcorp Holdings, Inc. quarterly revenues are $3.6B, which are smaller than Danaher Corp. quarterly revenues of $6.8B. Labcorp Holdings, Inc.'s net income of $261.5M is lower than Danaher Corp.'s net income of $1.2B. Notably, Labcorp Holdings, Inc.'s price-to-earnings ratio is 26.54x while Danaher Corp.'s PE ratio is 44.26x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Labcorp Holdings, Inc. is 1.65x versus 6.51x for Danaher Corp.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income LHLabcorp Holdings, Inc.1.65x 26.54x $3.6B $261.5M DHRDanaher Corp.6.51x 44.26x $6.8B $1.2B
-
Which has Higher Returns LH or GH?
Guardant Health, Inc. has a net margin of 7.34% compared to Labcorp Holdings, Inc.'s net margin of -34.97%. Labcorp Holdings, Inc.'s return on equity of 10.25% beat Guardant Health, Inc.'s return on equity of -8518.58%.
Company Gross Margin Earnings Per Share Invested Capital LHLabcorp Holdings, Inc.26.82% $3.12 $15.2B GHGuardant Health, Inc.64.71% -$0.74 $971.9M -
What do Analysts Say About LH or GH?
Labcorp Holdings, Inc. has a consensus price target of $300.06, signalling upside risk potential of 11.01%. On the other hand Guardant Health, Inc. has an analysts' consensus of $125.24 which suggests that it could grow by 9%. Given that Labcorp Holdings, Inc. has higher upside potential than Guardant Health, Inc., analysts believe Labcorp Holdings, Inc. is more attractive than Guardant Health, Inc..
Company Buy Ratings Hold Ratings Sell Ratings LHLabcorp Holdings, Inc.12 5 0 GHGuardant Health, Inc.16 1 1 -
Is LH or GH More Risky?
Labcorp Holdings, Inc. has a beta of 1.029, which suggesting that the stock is 2.876% more volatile than S&P 500. In comparison Guardant Health, Inc. has a beta of 1.631, suggesting its more volatile than the S&P 500 by 63.129%.
-
Which is a Better Dividend Stock LH or GH?
Labcorp Holdings, Inc. has a quarterly dividend of $0.72 per share corresponding to a yield of 1.07%. Guardant Health, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Labcorp Holdings, Inc. pays 32.58% of its earnings as a dividend. Guardant Health, Inc. pays out -- of its earnings as a dividend. Labcorp Holdings, Inc.'s payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.
-
Which has Better Financial Ratios LH or GH?
Labcorp Holdings, Inc. quarterly revenues are $3.6B, which are larger than Guardant Health, Inc. quarterly revenues of $265.2M. Labcorp Holdings, Inc.'s net income of $261.5M is higher than Guardant Health, Inc.'s net income of -$92.7M. Notably, Labcorp Holdings, Inc.'s price-to-earnings ratio is 26.54x while Guardant Health, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Labcorp Holdings, Inc. is 1.65x versus 15.80x for Guardant Health, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income LHLabcorp Holdings, Inc.1.65x 26.54x $3.6B $261.5M GHGuardant Health, Inc.15.80x -- $265.2M -$92.7M
-
Which has Higher Returns LH or WGS?
GeneDx Holdings Corp. has a net margin of 7.34% compared to Labcorp Holdings, Inc.'s net margin of -6.54%. Labcorp Holdings, Inc.'s return on equity of 10.25% beat GeneDx Holdings Corp.'s return on equity of 0.82%.
Company Gross Margin Earnings Per Share Invested Capital LHLabcorp Holdings, Inc.26.82% $3.12 $15.2B WGSGeneDx Holdings Corp.68.04% -$0.27 $406.6M -
What do Analysts Say About LH or WGS?
Labcorp Holdings, Inc. has a consensus price target of $300.06, signalling upside risk potential of 11.01%. On the other hand GeneDx Holdings Corp. has an analysts' consensus of $170.00 which suggests that it could grow by 71.7%. Given that GeneDx Holdings Corp. has higher upside potential than Labcorp Holdings, Inc., analysts believe GeneDx Holdings Corp. is more attractive than Labcorp Holdings, Inc..
Company Buy Ratings Hold Ratings Sell Ratings LHLabcorp Holdings, Inc.12 5 0 WGSGeneDx Holdings Corp.7 1 0 -
Is LH or WGS More Risky?
Labcorp Holdings, Inc. has a beta of 1.029, which suggesting that the stock is 2.876% more volatile than S&P 500. In comparison GeneDx Holdings Corp. has a beta of 2.078, suggesting its more volatile than the S&P 500 by 107.756%.
-
Which is a Better Dividend Stock LH or WGS?
Labcorp Holdings, Inc. has a quarterly dividend of $0.72 per share corresponding to a yield of 1.07%. GeneDx Holdings Corp. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Labcorp Holdings, Inc. pays 32.58% of its earnings as a dividend. GeneDx Holdings Corp. pays out -- of its earnings as a dividend. Labcorp Holdings, Inc.'s payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.
-
Which has Better Financial Ratios LH or WGS?
Labcorp Holdings, Inc. quarterly revenues are $3.6B, which are larger than GeneDx Holdings Corp. quarterly revenues of $116.7M. Labcorp Holdings, Inc.'s net income of $261.5M is higher than GeneDx Holdings Corp.'s net income of -$7.6M. Notably, Labcorp Holdings, Inc.'s price-to-earnings ratio is 26.54x while GeneDx Holdings Corp.'s PE ratio is 1,641.96x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Labcorp Holdings, Inc. is 1.65x versus 7.06x for GeneDx Holdings Corp.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income LHLabcorp Holdings, Inc.1.65x 26.54x $3.6B $261.5M WGSGeneDx Holdings Corp.7.06x 1,641.96x $116.7M -$7.6M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Where Will ISRG Stock Be in 5 Years?
Intuitive Surgical (NASDAQ:ISRG) is the innovative medical tech business behind…
Is Kratos Stock a Good Investment?
UAV and hypersonic system defense contractor Kratos (NASDAQ:KTOS) has swung…
Stock Ideas
Buy
55
Is NVDA Stock a Buy?
Market Cap: $4.5T
P/E Ratio: 63x
Buy
65
Is GOOG Stock a Buy?
Market Cap: $4.2T
P/E Ratio: 43x
Buy
51
Is GOOGL Stock a Buy?
Market Cap: $4.1T
P/E Ratio: 43x
Alerts
Sell
49
HYMC alert for Feb 3
Hycroft Mining Holding Corp. [HYMC] is up 19.68% over the past day.
Buy
67
FBRX alert for Feb 3
Forte Biosciences, Inc. [FBRX] is down 0.2% over the past day.
Buy
72
BNR alert for Feb 3
Burning Rock Biotech Ltd. [BNR] is down 15.43% over the past day.
